{"filings":[{"id":2033076,"accession_number":"0001000228-26-000043","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-08-04T10:13:53+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q2 GAAP EPS $0.82, non-GAAP $1.27; raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $3.5B (+6.7% YoY); GAAP net income $94M vs $86M; non-GAAP net income $145M vs $135M.","Non-GAAP diluted EPS $1.27 vs $1.10; adjusted EBITDA $288M vs $256M.","FY2026 guidance raised: non-GAAP EPS $5.29-$5.39 (prior $5.23-$5.37); sales growth 4.5%-5.5% (prior 3%-5%).","Adjusted EBITDA growth guidance raised to mid-to-high single digits from mid-single digits.","Repurchased 2.6M shares for $200M in Q2; YTD repurchases $325M; $455M remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1949861,"accession_number":"0001193125-26-324857","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-07-30T11:00:08+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein announces leadership transitions; three executives to become senior advisors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Ettinger (COO), Mark Mlotek (Chief Strategic Officer), and James Mullins (SVP Global Supply Chain) to transition out of roles effective Oct 30, 2026, and become senior advisors.","Company creates Henry Schein Leadership Team (HSLT) to replace Executive Management Committee.","Global supply chain organization to be integrated with global distribution group.","CEO Fred Lowery cites goal to simplify, accelerate decision-making, and become more customer-centric."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":591681,"accession_number":"0001193125-26-235496","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-05-22T12:00:11+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Henry Schein elects William K. Daniel as Independent Chairman; Bergman retires","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William K. Daniel elected Independent Chairman effective May 21, 2026.","Stanley M. Bergman retired from Board after 44 years, named Chairman Emeritus.","Daniel joined board in May 2025; former Danaher EVP overseeing dental portfolio.","CEO Fred Lowery thanked Bergman for transformative leadership and welcomed Daniel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90484,"accession_number":"0001000228-26-000021","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 GAAP EPS $0.92, non-GAAP $1.32; reaffirms 2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 GAAP diluted EPS $0.92 vs $0.88 YoY; non-GAAP diluted EPS $1.32 vs $1.15 YoY.","Net sales $3.4B, up 6.3% (2.5% internal growth); Adjusted EBITDA $289M vs $259M.","Reaffirmed 2026 guidance: non-GAAP EPS $5.23-$5.37, sales growth 3%-5%.","Repurchased 1.6M shares for $125M at avg $77.64; $655M remaining authorization.","Value creation initiatives targeting $200M+ operating income improvement; $125M run-rate by end-2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":3368000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100030,"accession_number":"0001000228-26-000010","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 sales +7.7%, non-GAAP EPS $1.34; 2026 guide $5.23-$5.37","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP EPS $0.85 vs $0.74; non-GAAP EPS $1.34 vs $1.19; total sales $3.4B (+7.7% YoY, internal 4.9%).","Global Dental equipment sales +12.2%; Specialty Products +14.6%; Technology +8.4% in Q4.","Full year 2025 sales $13.2B (+4.0%); non-GAAP EPS $4.97 vs $4.74; Adjusted EBITDA $1,101M.","2026 non-GAAP EPS guidance $5.23-$5.37; sales growth 3-5%; Adjusted EBITDA mid-single-digit growth.","Fred Lowery to join as CEO next week; repurchased $850M of shares in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":3.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":13184000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100029,"accession_number":"0001193125-26-009725","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"Henry Schein names Frederick Lowery as CEO effective March 2, 2026; Bergman remains Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Frederick Lowery (ex-Thermo Fisher EVP) succeeds Stanley Bergman as CEO; Bergman continues as Chairman.","Lowery receives $1.25M base salary, target bonus 150% of base, 2026 minimum bonus $1.875M.","2026 equity awards target value $10M (50% options, 25% RSUs, 25% performance RSUs); sign-on grant $2.5M.","Bylaws amended to eliminate requirement that CEO also be President or Chairman.","Amended executive severance plan now includes CEO eligibility for non-CIC severance benefits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116377,"accession_number":"0001193125-25-330853","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein expects to name next CEO by mid-January 2026; Bergman remains until successor assumes role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expects to appoint next CEO by mid-January 2026; search process nearing completion.","Stanley Bergman continues as CEO & Chairman until successor assumes the position.","Bergman entered into letter agreement extending employment until earlier of new CEO start or 30 days after his notice.","Search evaluated highly qualified candidates; Board expects final decision soon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116376,"accession_number":"0001193125-25-329486","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Henry Schein extends private shelf facility termination dates to Dec 19, 2028","summary_kind":"llm","event_type":"debt","confidence":"medium","bullets":["Amended shelf agreements with Prudential, NYL, MetLife, and Corebridge to extend termination to Dec 19, 2028.","Modifications made to certain financial definitions and covenants.","No new borrowing amount or interest rate changes disclosed in the filing.","Amendment covers the existing private shelf facilities; no material change in financial obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116375,"accession_number":"0001193125-25-311953","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"KKR designees Lin & Daniel to be renominated to Henry Schein board for 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KKR notified Henry Schein on Dec 7, 2025 of election to exercise Extension Election under Jan 29, 2025 Strategic Partnership Agreement.","Board will renominate Max Lin and William K. Daniel for election at 2026 Annual Meeting for a one-year term.","Extension Election is a contractual right of KKR as Investor Representative under the agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116374,"accession_number":"0001000228-25-000063","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q3 2025 non-GAAP EPS $1.38 vs $1.22; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP EPS $0.84 vs $0.78; non-GAAP EPS $1.38 vs $1.22; revenue $3.3B up 5.2% YoY.","Raises 2025 non-GAAP EPS guidance to $4.88-$4.96 (from $4.80-$4.94) and sales growth to 3-4% (from 2-4%).","Announces value creation initiatives targeting >$200M operating income improvement over next few years.","Board approved amendment allowing KKR to increase ownership up to 19.9%; KKR can buy open market.","Repurchased 3.3M shares for $229M in Q3; $980M remains authorized for future buys."],"consensus_eps_estimate":null,"consensus_eps_actual":2.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":9747000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132821,"accession_number":"0001193125-25-199164","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"James Breslawski leaves Henry Schein advisor role; receives severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Breslawski transitioned from President to Senior Advisor on April 1, 2025.","He left that role effective September 5, 2025.","Breslawski will receive payments and benefits under the Executive Severance Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132820,"accession_number":"0001000228-25-000042","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q2 GAAP EPS $0.70 (down 12.5% YoY); maintains FY25 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP net income $86M ($0.70 diluted EPS) vs $104M ($0.80) YoY; non-GAAP EPS $1.10 vs $1.23.","Total sales $3.2B, up 3.3% as-reported; internal growth 1.9%; Global Medical Distribution up 6.1%.","Adjusted EBITDA $256M vs $268M; recorded $23M restructuring costs targeting $100M+ annual run-rate savings.","FY25 guidance maintained: non-GAAP diluted EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit Adj. EBITDA growth.","Repurchased ~3.7M shares for $259M in Q2; $432M remaining for future repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":1.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":6408000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132819,"accession_number":"0001193125-25-159019","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Stanley M. Bergman to retire as Henry Schein CEO at end of 2025; will remain Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bergman to retire as CEO effective Dec 31, 2025, after 45 years at the company, over 35 as CEO.","Board initiates formal CEO search with external firm, considering internal and external candidates.","Bergman will remain Chairman of the Board following his retirement.","Under Bergman, revenue grew from $225M (1989) to ~$13B (2024), a 17.5% CAGR; market cap from $290M (IPO 1995) to ~$9B.","Company cites strong management in place; Andrea Albertini (Global Distribution/Technology) and Tom Popeck (Health Care Specialties) lead divisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149368,"accession_number":"0001193125-25-137473","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Henry Schein amends $750M term loan and $1B revolver, extends maturity to 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended and restated $750M term loan credit agreement, extending termination date to June 6, 2030.","Also amended and restated $1B revolving credit facility; modified financial definitions and covenants.","Proceeds for working capital, corporate purposes, stock repurchases, refinancing, and acquisitions.","Term loan jointly led by JPMorgan and U.S. Bank; revolver arranged by same syndicate plus additional co-documentation agents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149367,"accession_number":"0001193125-25-125917","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Henry Schein shareholders elect all 12 directors, approve say-on-pay and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 12 incumbent directors elected; Philip Laskawy received 20.6M against votes but still elected.","Max Lin and William K. 'Dan' Daniel elected as directors for terms expiring 2026.","Non-binding say-on-pay approved with 93.3M for, 12.2M against, 3.3M abstain.","Ratification of BDO USA as independent auditor for FY2025 passed with 107.9M for, 3.4M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149366,"accession_number":"0001193125-25-121679","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["1.01","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein closes $250M KKR investment; Dan Daniel joins board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KKR invested $250M for ~12% of HSIC common shares at ~$76.10/share in private placement.","William K. 'Dan' Daniel appointed as independent director effective May 16; joins Compensation and Strategic Advisory committees.","Max Lin, KKR partner, joined board May 2; appointed to Nominating & Governance and Strategic Advisory committees.","Transaction closed after expiration of HSR waiting period and regulatory approvals in Sweden, Italy, and Spain.","Proceeds expected to support HSIC's BOLD+1 strategy; no change to financial guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149365,"accession_number":"0001140361-25-017199","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 GAAP EPS $0.88 (+22% YoY); non-GAAP EPS $1.15 (+4.5%); maintains FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $3.2B; constant currency sales up 1.4% (2.0% ex-PPE/COVID test kits).","Global Distribution sales +0.8% constant currency; Medical +3.0%, Specialty +4.3%.","Repurchased $161M of stock (~2.3M shares at avg $71.58); $718M remaining authorization.","Restructuring costs $25M in Q1; expects annual run-rate savings at high end of $75M-$100M by end-2025.","FY2025 guidance unchanged: non-GAAP EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit EBITDA growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":3168000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149364,"accession_number":"0001193125-25-111677","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Henry Schein appoints KKR partner Max Lin to board; removes KKR voting commitment","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Max Lin, a KKR partner and head of Americas Health Care Private Equity, appointed to board effective May 2, 2025.","Board size increased to 15 directors; Lin will serve on Nominating/Governance and Strategic Advisory committees.","Regulatory conditions (HSR, Sweden/Italy approvals) for Lin's appointment satisfied as of April 10, 2025.","Lin receives standard non-employee director cash compensation (payable to KKR) but no equity grants.","Letter agreement deletes Section 5.11 of the KKR Strategic Partnership Agreement, removing investor's voting commitment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149363,"accession_number":"0001193125-25-080753","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-04-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein adopts executive severance plan with 1.5x multiple for officers; revises change-in-control plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee approved Executive Severance Plan effective April 10, 2025, covering members of Executive Management Committee (except CEO).","Severance multiples: 1.5x base salary+avg bonus for executive officers; 1.0x for others; paid over severance period.","Requires release of claims; includes pro-rata bonus, equity acceleration, COBRA subsidy up to 18 months, outplacement.","Contains non-compete, non-solicit, non-disparage covenants; violation triggers forfeiture and recoupment.","Amended CIC Plan adds non-duplication language to reduce benefits by any severance already paid under Severance Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149362,"accession_number":"0001193125-25-076218","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-04-09T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Henry Schein amends KKR voting commitment; allows KKR to follow ISS/Glass Lewis if Board differs","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Letter dated April 7, 2025 modifies the Jan 29, 2025 Strategic Partnership Agreement.","If both ISS and Glass Lewis recommend differently from Board on a stockholder proposal (excluding director elections/removals), KKR may vote its own discretion.","No other terms of the Partnership Agreement were amended or waived.","The amendment applies to all stockholder meetings during the Term, including written consents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168439,"accession_number":"0001193125-25-054483","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-03-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Henry Schein President Breslawski transitions to Senior Advisor effective April 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James P. Breslawski steps down as President of Henry Schein effective April 1, 2025.","He will serve as Senior Advisor and remain on the Executive Management Committee.","No successor named; company retains Breslawski in advisory capacity.","Transition is effective April 1, 2025, as reported March 11, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168438,"accession_number":"0001000228-25-000010","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 2024 non-GAAP EPS $1.19 vs $0.66; guides 2025 EPS $4.80-$4.94","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3.2B (+5.8% YoY); non-GAAP diluted EPS $1.19 (prior year $0.66).","Full-year 2024 non-GAAP EPS $4.74, revenue $12.7B; operating cash flow $848M, up $348M.","2025 non-GAAP EPS guidance $4.80-$4.94 (1-4% growth); sales growth ~2-4%.","New segments: Global Distribution & Value-Added ($10.8B), Specialty Products ($1.4B), Technology ($0.6B).","Restructuring $37M in Q4; expects $75-100M annual run-rate savings by end of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":3.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":12673000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168437,"accession_number":"0001193125-25-015654","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-01-29T23:59:59+00:00","items":["1.01","2.02","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein announces $250M KKR investment, preliminary Q4 EPS $1.19, and 2025 guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KKR to invest $250M at ~$76.10/share, becoming 12% common shareholder with board seats.","Preliminary Q4 2024: GAAP EPS $0.74, non-GAAP EPS $1.19; revenue $3.2B.","Full-year 2024 non-GAAP EPS $4.74; Adjusted EBITDA $1.061B.","2025 guidance: low-to-mid single-digit revenue and non-GAAP EPS growth; mid-single-digit EBITDA growth.","Board adds KKR designees Max Lin and William Daniel, plus independent director Robert Hombach; buyback authorization raised by $500M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185564,"accession_number":"0001000228-24-000062","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q3 GAAP EPS $0.78, non-GAAP $1.22; raises FY2024 non-GAAP EPS guidance to $4.74-$4.82","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total net sales $3.2B, up 0.4% YoY; internal sales down 2.6% reflecting cyber incident recovery and lower PPE sales.","Non-GAAP diluted EPS $1.22 vs $1.32 YoY; GAAP diluted EPS $0.78 vs $1.05 YoY.","Operating cash flow $151M in Q3; year-to-date $644M, up $112M vs 2023.","Raised FY2024 non-GAAP EPS guidance to $4.74-$4.82 (from $4.70-$4.82) and reaffirmed low-double-digit Adjusted EBITDA growth.","Recorded $48M restructuring costs in Q3; new 2024/2025 plan targeting $75-$100M annual run-rate savings by end of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":2.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":9482000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202149,"accession_number":"0001000228-24-000051","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q2 GAAP EPS $0.80 vs $1.06 YoY; lowers FY24 guidance, announces restructuring","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 total sales $3.1B (+1.1% YoY); internal sales down 2.4%.","GAAP diluted EPS $0.80; non-GAAP diluted EPS $1.23 vs $1.31 prior year.","FY24 non-GAAP EPS guidance cut to $4.70–$4.82 from $5.00–$5.16; sales growth lowered to ~4-6% from 8-10%.","New restructuring plan targets $75M–$100M annual run-rate savings.","Board authorized additional $500M share repurchase program."],"consensus_eps_estimate":null,"consensus_eps_actual":1.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":6308000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218199,"accession_number":"0001193125-24-147029","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Stockholders approve amended 2024 Stock Incentive Plan with 4.8M new shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate share reserve increased by 4,800,000 shares to a maximum of 75,742,657 shares.","Individual participant annual limit raised to 750,000 shares from prior limit.","Plan term extended to March 31, 2034 (previously March 31, 2030).","Clawback provisions added, including Dodd-Frank Clawback Policy effective Dec 1, 2023.","All 13 director nominees elected; say-on-pay approved (101.4M for, 13.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218198,"accession_number":"0001000228-24-000022","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 sales $3.2B, GAAP EPS $0.72; tightens 2024 sales growth guidance to 8-10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 total sales $3.2B (+3.7% YoY); internal sales -1.8% due to cyber incident (300-400 bps drag) and lower glove pricing.","GAAP diluted EPS $0.72 vs $0.91 YoY; non-GAAP diluted EPS $1.10 vs $1.21 YoY.","Adjusted EBITDA $255M, flat YoY; 2024 Adj. EBITDA growth >15% reaffirmed.","2024 non-GAAP EPS guidance reaffirmed at $5.00-$5.16; total sales growth guidance narrowed to 8%-10% from 8%-12%.","Repurchased ~1M shares for $75M at avg $75.10; $190M remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":0.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":3172000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238173,"accession_number":"0001000228-24-000008","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 GAAP EPS $0.13, non-GAAP $0.66; guides 2024 EPS $5.00-$5.16","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $3.0B (-10.5% YoY); estimated $350M-$400M reduction from cybersecurity incident.","Q4 GAAP diluted EPS $0.13; non-GAAP diluted EPS $0.66, reflecting $0.70-$0.75 cyber impact.","Full-year 2023: revenue $12.3B, GAAP EPS $3.16, non-GAAP EPS $4.50.","2024 guidance: non-GAAP EPS $5.00-$5.16 (11%-15% growth); sales growth ~8%-12%; Adjusted EBITDA >15% growth.","Residual cyber impact ~$0.15 in Q1 2024; tax rate expected to rise to ~25%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":12339000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255628,"accession_number":"0001193125-23-297629","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-12-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein appoints Carole T. Faig as independent director; board expands to 15","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Carole T. Faig appointed effective Dec 13, 2023; will serve until 2024 annual meeting, expected to stand for re-election.","Faig brings 38-year Ernst & Young career, most recently as U.S. Health Leader and West Region Health and Life Sciences Leader.","Board increased size to 15 directors to fill vacancy; Faig is independent and chairs audit committees at three other companies.","Amendment Number Four to Supplemental Executive Retirement Plan approved, effective Jan 1, 2024, allowing joint ventures 50%+ owned to participate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255627,"accession_number":"0001193125-23-278944","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-11-16T23:59:59+00:00","items":["3.01","5.02","9.01"],"status":"ready","headline":"Henry Schein receives Nasdaq deficiency notice for delayed Q3 10-Q due to Oct cyber incident","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified HSIC on Nov 13, 2023 of non-compliance with Listing Rule 5250(c)(1) for missing Q3 10-Q filing deadline of Nov 14.","Delay stems from information access limits after Oct 14 cybersecurity incident that caused precautionary system shutdown.","HSIC has 60 days to submit a compliance plan; expects to file the 10-Q before end of November 2023.","Compensation Committee also amended Deferred Compensation Plan, raising salary deferral threshold to $225,000 effective Nov 14.","Amended plan permits joint-venture entities to participate and allows one change to distribution form upon termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255626,"accession_number":"0001000228-23-000046","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q3 non-GAAP EPS $1.32; lowers FY guidance to $4.43-$4.71 on cyber incident and macro headwinds","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP diluted EPS $1.05, non-GAAP diluted EPS $1.32; revenue $3.2B (+3.1% YoY).","FY 2023 non-GAAP EPS guidance lowered to $4.43-$4.71 from $5.18-$5.35; includes $0.55-$0.75 cyber incident impact.","Cybersecurity incident discovered Oct 14; ecommerce reactivation underway; expects Q3 10-Q by end of November.","Global Dental +5.4%, Global Medical -3.1%, Global Technology +18.8% YoY.","Acquired $417M in Q3; repurchased 660K shares for $50M."],"consensus_eps_estimate":null,"consensus_eps_actual":3.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":9322000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255625,"accession_number":"0001193125-23-269356","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Henry Schein to webcast Q3 results Nov 13, update FY guidance after cyber incident","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q3 2023 earnings release and webcast scheduled for Nov 13 at 10 a.m. ET.","Company to update full-year 2023 guidance and discuss costs of recovery from cybersecurity incident.","Q3 Form 10-Q filing delayed due to cyber incident; expects to file by end of November 2023.","Prior cybersecurity incident (Oct 16, 2023) led to application shutdown and operational disruption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255624,"accession_number":"0001193125-23-261152","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-10-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Henry Schein updates on cybersecurity incident recovery; order fulfillment normalizing","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["US and Canada distribution centers shipping orders within 1-2 business days, including consumables and small equipment.","European distribution businesses operational, taking and shipping orders; Australia, New Zealand, Asia, Brazil fully operational.","Henry Schein One (practice management tech) and most manufacturing operations unaffected by the incident.","Equipment service and installation teams have remained fully operational throughout the incident.","Company plans to disclose further information via its investor relations page, SEC filings, and press releases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255623,"accession_number":"0001193125-23-256465","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-10-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Henry Schein reports Oct 14 cyber incident disrupting manufacturing and distribution","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Determined on Oct 14 that a portion of manufacturing/distribution systems experienced a cyber incident; systems taken offline.","Client-facing practice management software not disrupted; Company engaged forensic experts and notified law enforcement.","Incident caused temporary disruption to some business operations; investigation ongoing regarding data impact.","No financial impact or data compromise details disclosed yet; Company thanks customers and suppliers for patience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273076,"accession_number":"0001000228-23-000041","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q2 GAAP EPS $1.06, Non-GAAP $1.31; Revenue $3.1B; Affirms FY Guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $140M ($1.06/diluted share) vs Q2 2022 $160M ($1.16); non-GAAP $173M ($1.31) vs $179M ($1.30).","Total sales $3.1B (+2.3%); internal sales ex-PPE/COVID test kits +3.3% in local currencies; global dental +5.6% to $2.0B.","PPE & COVID test kit sales $163M, down $96M YoY; impact on EPS estimated at $0.08/diluted share.","FY 2023 non-GAAP EPS guidance reaffirmed at $5.18-$5.35; PPE sales now expected to decline 25%-30% (prior ~20-25%).","Committed over $1B to acquisitions YTD; closed new $750M credit facility in July 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":6160000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273075,"accession_number":"0001193125-23-186248","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-07-13T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Henry Schein secures new $750M term loan and amends $1B revolver, boosting total liquidity to $1.8B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $750M unsecured term loan facility matures July 2026; for working capital, acquisitions, stock buybacks.","Existing $1B revolver amended and restated; maturity extended to July 2028.","Combined borrowing capacity now $1.8B; CFO says supports BOLD+1 strategic plan and M&A.","Facilities contain customary covenants and events of default; term loan priced at Term SOFR plus spread."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289921,"accession_number":"0001193125-23-154352","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-05-25T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Henry Schein shareholders approve 2023 Director Stock Plan with 275k additional shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate share reserve increased by 275,000 to 2,075,000 shares under the renamed 2023 Non-Employee Director Stock Incentive Plan.","Plan term extended until May 23, 2033; minimum vesting of one year introduced for all new awards.","Annual limit on director compensation set at $900,000 (equity plus cash) per fiscal year.","All 14 director nominees elected; plan approved with ~93% of votes cast in favor.","Say-on-pay approved (~92% support); frequency of say-on-pay set at one year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289920,"accession_number":"0001000228-23-000024","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 revenue down 3.8% to $3.1B; non-GAAP EPS $1.21 vs $1.44; lowers 2023 guidance to $5.18-$5.35","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $0.91 vs $1.30; non-GAAP diluted EPS $1.21 vs $1.44.","Net sales $3.1B, down 3.8% YoY; internal sales grew 6.3% ex-PPE and COVID test kits.","Global Medical sales $1.0B down 17.2% (up 4.2% ex-PPE/COVID test kits); Dental $1.9B up 3.8%.","2023 non-GAAP EPS guidance cut to $5.18-$5.35 from prior $5.38; includes $0.05-$0.10 Biotech Dental dilution.","Repurchased 1.2M shares for $100M in Q1; $415M remains authorized for buybacks."],"consensus_eps_estimate":null,"consensus_eps_actual":0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":3060000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310872,"accession_number":"0001193125-23-079156","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-03-24T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Henry Schein amends By-Laws regarding advance notice, universal proxy rules, and proxy card color","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Requires notice of nominations or business 120 to 90 days before annual meeting anniversary.","Adds compliance requirements with universal proxy rules (Rule 14a-19) and group certification.","Revises advance notice: stockholders must provide info within 5 days of request; nominees may be interviewed.","Requires stockholders soliciting proxies to use a non-white proxy card.","Includes ministerial, clarifying, and conforming changes for consistency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310871,"accession_number":"0001193125-23-049547","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Henry Schein hosts Investor Meeting to detail BOLD+1 Strategic Plan and long-term financial goals","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Investor Meeting on Feb 27, 2023 in NYC at 9 a.m. EST; webcast at henryschein.com/IRwebcasts.","Management to present BOLD+1 Strategic Plan for sustainable growth and long-term financial goals.","Progress highlighted on specialty products, technology, digital transformation, and ESG priorities.","2023 financial guidance referenced; 2022 sales reached $12.6B with 12.1% CAGR since 1995.","CEO Stanley Bergman cites strong end-market fundamentals and unique positioning for growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310870,"accession_number":"0001000228-23-000006","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2023-02-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 non-GAAP EPS $1.21 beats year-ago $1.07; guides FY23 $5.25-$5.42","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $3.4B, +1.2% as reported; internal sales ex-PPE/COVID test kits +5.0% in local currencies.","GAAP diluted EPS $0.34 (incl. $121M restructuring, $34M impairment) vs $1.05 prior year; non-GAAP $1.21 vs $1.07.","Full-year 2022 non-GAAP EPS $4.81, up from $4.51; FY23 guidance $5.25-$5.42, excluding amortization.","Board authorized additional $400M stock repurchase; Q4 bought ~3.6M shares for $285M at avg $79.55.","Expects FY23 sales growth ~1-3%, PPE/COVID test kit sales to decline ~30-35%; operating margin ~10-15 bps below 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":3.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":12647000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329474,"accession_number":"0001193125-22-293869","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-11-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein amends CEO Bergman's employment agreement, extends term to Dec 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary set at $1,582,000 per annum; term expires Dec 31, 2025 with possible one-year extensions.","No cash severance if company non-renews; target incentive comp and equity awards tied to peer group medians.","Annual equity awards from 2023 target total direct comp at least 50th percentile and equity grant at least median of peer group.","Vesting acceleration upon death, disability, termination w/o cause, good reason, retirement, or non-renewal, with change-in-control provisions.","Technical updates include definition of Good Reason and conforming changes to align with updated terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329473,"accession_number":"0001000228-22-000066","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-11-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein reports record Q3 non-GAAP diluted EPS of $1.15; narrows FY2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $3.1B (-3.5% YoY); internal sales ex-PPE/COVID test kits +6.8% in local currencies.","GAAP diluted EPS $1.09 vs $1.15; Non-GAAP diluted EPS $1.15 vs $1.10 (record).","Global Dental internal sales +1.2% local currency; Medical internal sales ex-PPE/COVID +9.3%.","FY2022 non-GAAP EPS guidance narrowed to $4.79-$4.87; sales growth guidance lowered to ~1.5-2.5%.","Repurchased 1.2M shares for $90.5M in Q3; $400M remaining in buyback authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":3.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":9276000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347074,"accession_number":"0001000228-22-000053","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-08-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein posts record Q2 sales $3.0B, EPS $1.16; lowers full-year sales guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $3.0B (+2.1% YoY); internal sales ex-PPE/COVID up 6.7% in local currencies.","GAAP diluted EPS $1.16 vs $1.10 YoY; non-GAAP EPS $1.11 in Q2 2021.","Affirms FY2022 GAAP EPS guidance $4.75-$4.91; cuts sales growth guidance to 3%-6% from 5%-8% due to FX and lower COVID test kits.","Announces restructuring plan to streamline operations; charges expected in 2022-2023, amount not yet determined.","Repurchased 1.3M shares for $110M in Q2 at avg price $81.42/share."],"consensus_eps_estimate":null,"consensus_eps_actual":2.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":6209000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363458,"accession_number":"0001193125-22-156133","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-05-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Henry Schein elects all directors, say-on-pay approved with narrow 51.5% support","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 15 director nominees elected; Stanley M. Bergman received 109.96M for, 9.75M against.","Say-on-pay proposal approved with 61.1M for and 57.5M against (51.5% support).","Ratification of BDO USA as auditor for FY2022 passed with 115.5M for, 9.78M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363457,"accession_number":"0001000228-22-000030","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 record sales $3.2B (+8.7% YoY), EPS $1.30 beats prior year; reaffirms FY2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $3.2B, +8.7% YoY; GAAP diluted EPS $1.30 vs $1.16 YoY.","Global Dental sales $1.8B (+2.2% YoY); Global Medical $1.2B (+18.3%).","Global Technology & Value-Added Services sales $179M (+23.4%), driven by Henry Schein One.","FY2022 GAAP EPS guidance reaffirmed $4.75-$4.91 (7-10% growth); sales growth guidance narrowed to 5-8%.","$200M remaining in share repurchase authority; no shares bought in Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":1.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":3179000000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363456,"accession_number":"0001193125-22-094333","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-04-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein CAO Benjamin to retire July 1, 2022; Ettinger appointed COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gerald A. Benjamin to retire as EVP & CAO effective July 1, 2022, after 34 years.","Benjamin will not stand for reelection to the Board at the May 2022 Annual Meeting.","Michael S. Ettinger promoted to EVP & COO, effective July 1, 2022, reporting to CEO.","Ettinger, with the company since 1994, previously SVP Corporate & Legal Affairs and Chief of Staff.","Benjamin led global supply chain (5.6M sq ft, 27 distribution centers) and will remain as adviser."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383268,"accession_number":"0001000228-22-000013","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-02-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein reports record Q4 non-GAAP EPS $1.07, FY sales $12.4B; guides FY22 EPS $4.75–$4.91","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $3.3B (+5.2% YoY); GAAP EPS $1.05, non-GAAP EPS $1.07 vs. $1.00 last year.","FY 2021 sales $12.4B (+22.6%); GAAP EPS $4.45, non-GAAP EPS $4.52 vs. $2.97 last year.","Global Dental Q4 sales $2.0B (+9.4%); internal growth 6.4% in local currencies.","Global Technology & Value-Added Services Q4 sales $177.2M (+27.8%), internal growth 13.4%.","Board authorized $200M remaining for stock repurchases; bought 2M shares at $75.50/avg in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":4.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":12401021000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383267,"accession_number":"0001193125-22-002148","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2022-01-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein CFO Steven Paladino to retire April 29, 2022; Ronald South named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Steven Paladino retires after 35 years, 29 as CFO; will remain on Board and consult.","Ronald South, VP Corporate Finance & CAO since 2008/2013, promoted to SVP & CFO effective April 29.","Olga Timoshkina, joined Sept 2021 as VP Corporate Controller, becomes VP Corporate Finance & CAO.","Paladino's tenure saw net sales CAGR ~12% since 1995 IPO; no new financial guidance issued.","Succession plan reflects orderly transition; South to join Executive Management Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401057,"accession_number":"0001193125-21-350793","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2021-12-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein appoints Scott Serota to board; Barry Alperin to retire in May 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Serota, former CEO of Blue Cross Blue Shield Association, appointed to Henry Schein board effective Dec 7, 2021.","Serota will serve on Strategic Advisory Committee; stands for re-election at 2022 annual meeting.","Barry Alperin to retire from board in May 2022 after reaching age 80; served since 1996.","Alperin continues as member of Audit, Compensation, and Nominating committees until retirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2021-12-08T23:59:59+00:00|401057"}